ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

MLR Maelor

100.00
0.00 (0.00%)
05 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Maelor LSE:MLR London Ordinary Share GB00B2QBY649 ORD 70P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 100.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

AGM Statement

02/08/2006 8:03am

UK Regulatory


RNS Number:1030H
Maelor PLC
02 August 2006


                                   Maelor plc

                                 AGM Statement


2 August 2006:  Maelor plc ("Maelor"; AIM:MLR), the specialist critical care
company is today providing the following update on current trading at its Annual
General Meeting:


"At the time of June's announcement of the Company's results for the financial
year ended 31 March 2006, we noted that the year had been one of significant
change for the Company. Maelor began its transformation into a business with a
clear focus under new leadership. We are pleased to confirm that it continues to
make good progress under the guidance and strong leadership of our new Chief
Executive Officer, Tim Wright.


In the second half of the last financial year the Company rigorously evaluated
its existing portfolio and competencies and as a result developed a clear
strategy focused on transforming Maelor into a specialist critical care
business, while leveraging its non critical care portfolio through efficient
partnerships.


Trading in the early part of the current financial year has been encouraging and
in line with management's expectations. The strategy is being implemented and we
are moving forward with a number of projects. Progress includes the active
direct promotion of the critical care brand Volplex as well as implementation of
the licensing agreement announced in June with Plethora Solutions. This
agreement will enable the development of a treatment for interstitial cystitis
and painful bladder syndrome, for which the Company has received an upfront
payment and will receive milestone and royalty payments.


Since the year end the management team has been further strengthened in order to
deliver the new strategy.  A Commercial Director, experienced in the field of
critical care, has been appointed to lead our sales and marketing activities and
we are delighted to welcome Nigel Goldsmith to the Board as Finance Director and
Company Secretary.


With a clear strategy and a management team that has the ability and commitment
to deliver, the Board is looking to the future with confidence."


Enquiries:


Maelor plc, Tim Wright, CEO,

Tel: 01978 810153



Financial Dynamics, Billy Clegg/Andrew White,

Tel: 020 7831 3113



                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

AGMSSISMESMSEFA

1 Year Maelor Chart

1 Year Maelor Chart

1 Month Maelor Chart

1 Month Maelor Chart

Your Recent History

Delayed Upgrade Clock